BDBM165355 US9062043, Table 13, Compound 22::US9062043, Table 20b, Compound 15
SMILES: OC(=O)c1ccc2c(c1)nc(Nc1cccc(c1)C#C)c1ncncc21
InChI Key: InChIKey=HJGFPNFAFSFDNN-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Casein kinase II subunit alpha (Homo sapiens (Human)) | BDBM165355 (US9062043, Table 13, Compound 22 | US9062043, Tabl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid PDB UniChem Similars | PDB Article PubMed | 420 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
China Pharmaceutical University Curated by ChEMBL | Assay Description Inhibition of CK2alpha (unknown origin) using RRRADDSDDDDD as substrate in presence of [gamma33P]-ATP by autoradiography | Eur J Med Chem 181: (2019) Article DOI: 10.1016/j.ejmech.2019.111581 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Casein kinase II subunit alpha (Homo sapiens (Human)) | BDBM165355 (US9062043, Table 13, Compound 22 | US9062043, Tabl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | 7.2 | n/a |
SENHWA BIOSCIENCES, INC. US Patent | Assay Description Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A... | US Patent US9062043 (2015) BindingDB Entry DOI: 10.7270/Q20G3HWF | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Casein kinase II subunit alpha (Homo sapiens (Human)) | BDBM165355 (US9062043, Table 13, Compound 22 | US9062043, Tabl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | 98 | n/a | n/a | n/a | n/a | 7.4 | n/a |
SENHWA BIOSCIENCES, INC. US Patent | Assay Description The human leukemia Jurkat T-cell line was maintained in RPMI 1640 (Cambrex) supplemented with 10% fetal calf serum and 50 ng/ml Geutamycin. Before tr... | US Patent US9062043 (2015) BindingDB Entry DOI: 10.7270/Q20G3HWF | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) |